Clinical
RESOURCES
Ensuring an Open Channel with Regulatory and Medical Policy Opinion Leaders During COVID
Many companies, particularly new entrants into the U.S. pharma arena, are facing some level of disruption or impact on their projected timelines for seeking FDA licensure, gathering data from trials for filing, conducting health economics analyses needed to demonstrate improved outcomes, or conducting real-world evidence studies that can help inform medical societies’ deliberations on clinical […]
View2020 and the luxury of limitations for clinical trials
COVID-19 has had a fundamental effect on every aspect of society, including clinical trials. The search for an effective vaccine or treatment for COVID-19 continues to move at record pace. However, many clinical trials in other therapeutic areas have either been delayed or essentially ground to a halt due to the pandemic. Such delays place […]
ViewAssessing and managing issues around clinical trials: a multi-stakeholder approach
Many companies are facing challenging decisions on whether to proceed with clinical trials in the coming months as countries experience varying degrees of lockdown.
ViewVirtual training that excites
This virtual meeting and training infographic provides useful tips on how to make the most of virtual meetings by bridging the gap between a face-to-face experience and a virtual environment.
Download PDFSupporting study participants
We have developed a checklist of reminders for the site staff who are at the frontlines interacting with participants, patients and caregivers. This checklist offers practical reminders to enhance their day-to-day interactions with study participants.
Download PDFUnlocking virtual medical congresses
Medical congresses – crucial for the presentation of trial data, scientific exchange and the opportunity to engage with medical professionals, patient advocates, media and analysts – have been cancelled, postponed or are moving to virtual/part virtual.
ViewNo two virtual congresses are the same
Each congress has a different structure to its overall program and method in delivering its scientific information, despite stating that they all plan to keep to the traditional congress format.
Download PDFGet in Touch
We know there are numerous considerations when it comes to the impact of COVID-19 on clinical trials and what this means for your organization. We are here to help.